Briggs of Burton was represented at the Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2026) by Jonathan Roden, Life Sciences Strategic Development Manager, reinforcing the company’s engagement with the global Life Sciences sector.
PHARMAP 2026 provided a strategically relevant platform to discuss evolving industry needs and current investment priorities, with a clear focus on practical, near-term solutions rather than early-stage concepts.
Across the two-day programme, sessions explored forward-looking approaches to pharmaceutical manufacturing, including the integration of AI and digital tools into production, alongside strategies for optimising both outsourced and in-house manufacturing models.
The programme highlighted growing demand for digitalisation, compliant production systems, and secure supply chains – reinforcing Briggs of Burton’s relevance within the Life Sciences sector where robust engineering, process expertise and strategic collaboration are critical.
